Note: This is the first of a series of articles on remuneration. By Mak Yuen Teen Many years ago, I spoke at an overseas conference where one participant mentioned that disclosing remuneration in annual reports makes their...
Read MoreNote: This post was updated on 31 December 2021 at 4.45 pm and then further updated at 7 pm. Last night, ASTI Holdings posted a “clarification announcement” in response to my earlier post about the payment made to...
Read MoreNote: This post was updated on 25 December 2021 at 12 pm to provide more detail on what contributed to the change of fortunes in FY2019 for ASTI and DGI. _________________ On 23 December, I made a post titled “ASTI Holdings: A...
Read MoreOn 22 December 2021, ASTI Holdings announced that it has decided to terminate the appointment of Dato’ Michael Loh Soon Gnee as CEO as part of its retrenchment exercise. He is to remain as Chairman. The company said that...
Read MoreBy Mak Yuen Teen and Wesley Loo Kangmei Pharmaceutical Co. (“Kangmei”), a Fortune China 500 company in 2018[1], was a large Chinese medicine producer based in Guangdong province[2]. Its primary business revolved around the...
Read More
